Seeking Alpha

ARGS
  Argos Therapeutics, Inc. - NASDAQ

8/22/2014, 8:48 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ARGS vs. ETF Alternatives
Company Description
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform. Argos' most advanced product candidate, AGS-003, is being... More